Company

Trevi Therapeutics, Inc.

TRVI · CIK 0001563880

SEC FORM 4

$55,999.84

Acquisition (code M) of 18,421 shares at $3.04 per share.

Reporting Person Heffernan Michael Thomas · Transaction Code M

Traded Sep 15, 2026 · Disclosed Sep 17, 2026

Source: SEC Form 4 · 0001193125-26-394456 · filed 2026-09-17 · View filing →

SEC FORM 4

$276,463.89

Sale of 18,321 shares at $15.09 per share.

Reporting Person Heffernan Michael Thomas · Transaction Code S

Traded Sep 15, 2026 · Disclosed Sep 17, 2026

Source: SEC Form 4 · 0001193125-26-394456 · filed 2026-09-17 · View filing →

SEC FORM 4

$1,588.00

Sale of 100 shares at $15.88 per share.

Reporting Person Heffernan Michael Thomas · Transaction Code S

Traded Sep 15, 2026 · Disclosed Sep 17, 2026

Source: SEC Form 4 · 0001193125-26-394456 · filed 2026-09-17 · View filing →

SEC FORM 4

$70,103.16

Acquisition (code M) of 21,052 shares at $3.33 per share.

Reporting Person Heffernan Michael Thomas · Transaction Code M

Traded Sep 15, 2026 · Disclosed Sep 17, 2026

Source: SEC Form 4 · 0001193125-26-394456 · filed 2026-09-17 · View filing →

SEC FORM 4

$316,165.68

Sale of 20,952 shares at $15.09 per share.

Reporting Person Heffernan Michael Thomas · Transaction Code S

Traded Sep 15, 2026 · Disclosed Sep 17, 2026

Source: SEC Form 4 · 0001193125-26-394456 · filed 2026-09-17 · View filing →

SEC FORM 4

$1,588.00

Sale of 100 shares at $15.88 per share.

Reporting Person Heffernan Michael Thomas · Transaction Code S

Traded Sep 15, 2026 · Disclosed Sep 17, 2026

Source: SEC Form 4 · 0001193125-26-394456 · filed 2026-09-17 · View filing →